Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Profound Medical (PROF) Net Margin (2019 - 2026)

Profound Medical has reported Net Margin over the past 7 years, most recently at 1287.69% for Q4 2025.

  • For Q4 2025, Net Margin rose 7396.0% year-over-year to 1287.69%; the TTM value through Dec 2025 reached 264.44%, down 328.0%, while the annual FY2025 figure was 264.44%, 399.0% up from the prior year.
  • Net Margin for Q4 2025 was 1287.69% at Profound Medical, up from 150.82% in the prior quarter.
  • Over five years, Net Margin peaked at 1387.22% in Q4 2022 and troughed at 6730.89% in Q4 2023.
  • A 5-year average of 326.94% and a median of 254.91% in 2022 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: plummeted -811811bps in 2023 and later soared 794461bps in 2024.
  • Year by year, Net Margin stood at 5109.82% in 2021, then soared by 127bps to 1387.22% in 2022, then plummeted by -585bps to 6730.89% in 2023, then surged by 118bps to 1213.72% in 2024, then rose by 6bps to 1287.69% in 2025.
  • Business Quant data shows Net Margin for PROF at 1287.69% in Q4 2025, 150.82% in Q3 2025, and 709.86% in Q2 2025.